- September 20, 2023
Smilow Shares CME: Perspectives on the USPSTF Breast Screening Recommendations
- August 15, 2023Source: Everyday Health
Breast Cancer Is Often Overdiagnosed in Older Women, Study Suggests
- August 15, 2023Source: Health
Study: Breast Cancer Screening May Not Be as Helpful for Older Women
- August 09, 2023
Study: Low-Risk Long-Term Cancer Survivors Much More Likely to Die of Noncancer Causes
- August 07, 2023
Screening Mammograms Carry Risks for Older Women, Study Finds
- August 07, 2023Source: CNN
Older women’s breast cancer is often overdiagnosed, study finds, raising risk of unnecessary treatment
- July 13, 2023Source: The Lancet Oncology
Egypt launches 100 Healthy Days health-care campaign
- July 11, 2023
Dr. Maureen Canavan on Yale Cancer Answers
Welcome to the COPPER Center!
The mission of the COPPER Center at Yale is to improve cancer care and to decrease the burden of cancer on individual patients as well as society. Led by Cary P. Gross, MD, the Center is comprised of researchers and clinicians from across the Yale Schools of Medicine (Therapeutic Radiology, Surgical Oncology, Hematology/Medical Oncology, OB/GYN, Urology, and Internal Medicine) and Public Health (Epidemiology and Health Policy). We also provide training and mentorship to the next generation of cancer policy and outcomes researchers.
Goals:
- Generate and disseminate new information that can improve the care and outcomes of patients with cancer.
- Develop and refine new research methods and data resources.
- Train and engage clinicians and researchers in the conduct of cancer-related outcomes, policy, and effectiveness research.
Center members currently collaborate on a wide spectrum of translational cancer research projects, employing expertise in clinical epidemiology, comparative effectiveness, and health services research across a variety of cancer types (breast, colon, head and neck, lung, prostate, bladder, and hematological malignancies) and clinical settings. COPPER investigators employ state of the art techniques to shed new light on the care and outcomes of older persons with cancer. The group has considerable experience analyzing large datasets, including cancer registry and administrative claims data, and collecting primary data.
In addition to COPPER's prominence in the scientific community, our research has been featured in high-impact lay publications such as The New York Times, The Wall Street Journal, and The Washington Post. Furthermore, our work has been cited in payer coverage decisions and medical society clinical guidelines. In 2019, COPPER research conducted in collaboration with Flatiron Health was selected for presentation at the ASCO Annual Meeting Plenary Session. For more information on this presentation and associated press coverage, please click here.